Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

53.61
BATS BZX Real-Time Price
As of 12:11pm ET
 -0.98 / -1.80%
Today’s Change
46.01
Today|||52-Week Range
77.12
-8.26%
Year-to-Date
Factor Xa's Win Billions of Dollars in Sales From Warfarin
11:11am / MotleyFool.com - Paid Partner Content
Jana Partners Buys HD Supply Holdings, Bristol-Myers Squibb Company, Salesforce. ...
Feb 14 / GuruFocus News - Paid Partner Content
Your Burning Biotech Questions Answered
Feb 20 / TheStreet.com - Paid Partner Content
3 Stocks We're Watching in the First Quarter
Feb 14 / MotleyFool.com - Paid Partner Content
Your Burning Biotech Questions Answered
Feb 17 / TheStreet.com - Paid Partner Content
Valeant's Stock Having One Of Its Best Days Of 2017
Feb 14 / Benzinga - Paid Partner Content
Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb 17 / Zacks.com - Paid Partner Content
Holland Capital Management Llc Buys UnitedHealth Group, Under Armour, D.R. ...
Feb 14 / GuruFocus News - Paid Partner Content
Jarislowsky, Fraser Ltd Buys Quintiles IMS Holdings, Gildan Activewear, Dominion Reso...
Feb 17 / GuruFocus News - Paid Partner Content
Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb
Feb 13 / MotleyFool.com - Paid Partner Content
Laffer Investments Buys Schlumberger, Medtronic PLC, Union Pacific, Sells Apple, Exxo...
Feb 17 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi
Feb 10 / Zacks.com - Paid Partner Content
Marco Investment Management Llc Buys Johnson Controls International PLC, Amgen, AbbVi...
Feb 16 / GuruFocus News - Paid Partner Content
Brakes on the pathway to treating cancer
Feb 09 / FT.com - Paid Partner Content
David Tepper Invests Heavily in Pharma in 4th Quarter
Feb 16 / GuruFocus News - Paid Partner Content
Gilead (GILD) Beats Q4 Earnings & Sales, View Disappoints
Feb 08 / Zacks.com - Paid Partner Content
How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
Feb 16 / MotleyFool.com - Paid Partner Content
Earnings No Longer a Headwind for Stocks
Feb 07 / Zacks.com - Paid Partner Content
Biotech Buoyed by Deal Talk
Feb 15 / TheStreet.com - Paid Partner Content
Merck hails rise in patient tests for immunotherapy drug Keytruda
Feb 02 / FT.com - Paid Partner Content